Skip to main content

HOLLENCREST CAPITAL MANAGEMENT

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1161722 NEWPORT BEACH, CA

Position in SUPN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,720
-$415 QoQ
Shares Held
80
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#285
of 331 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

HOLLENCREST CAPITAL MANAGEMENT holds $310,202 across 9 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 SUPN
Supernus Pharmaceuticals, Inc.
This page
80 $3,720

All Filings in SUPN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,720 80
2026-03-31 $4,135 80
2025-12-31 $3,976 80
2025-09-30 $3,823 80
2025-06-30 $2,521 80
2025-03-31 $2,620 80
2024-12-31 $2,892 80
2024-09-30 $2,494 80
2024-06-30 $2,140 80
2024-03-31 $2,728 80
2023-12-31 $2,315 80
2023-09-30 $2,205 80
2023-06-30 $2,404 80
2023-03-31 $2,898 80
2022-12-31 $2,853 80